Cannabis Science, Inc. is the front line in pharmaceutical grade medical marijuana research and development.
By Michael Komorn
Cannabis Science, Inc. is a pioneering US biotech company that is developing pharmaceutical cannabis products in its mission to educate the public on the benefits of cannabis. Throughout their mission they have developed and now released a growing list of peer-reviewed, cannabis and cancer references from researchers around the world.
(Related: Michigan Supreme Court rules driving with any presence of marijuana protected by the MMMA)
Dr. Robert Melamede, president of Cannabis Science said, “This list of peer-reviewed manuscripts, provides support for the anecdotal observations of an increasing number of patients claiming successful cancer treatment using medical cannabis extracts. The scientific documentation of the anti-cancer and anti-metastatic properties of cannabinoids is a driving force behind behind our long-term goal, to make high quality, effective, reliable and safe cannabis extracts available to the public beyond the borders of current medical marijuana states. We continue to receive a constant flow of patent inquiries as to what treatment options are available. Currently, two Cannabis Science extracts are available in one Colorado-licensed medical marijuana dispensary (Cannabis Therapeutics). One product is grown hydroponically, whereas the second preparation is grown in soil.”
(Related: Michigan Welfare Drug Testing Law Needs Medical Marihuana Exemption)
Below you can discover the selected references that are evidence of both the breadth and depth of the anticancer activities possessed by cannabinoids.
Peer Reviewed Cannabis and Cancer References resulting from a PubMed search (NIH database of biomedical research).
1. Proto, M. C. et al. Interaction of endocannabinoid system and steroid Hormones in the control of colon cancer cell growth. J Cell Physiol 227, 250-258 (2012).
2. Hermanson, D. J. & Marnett, L. J. Cannabinoids, endocannabinoids, and cancer. Cancer Metastasis Rev (2011).
3. Bowles, D. W., O’Bryant, C. L., Camidge, D. R. & Jimeno, A. The intersection between cannabis and cancer in the United States. Crit Rev Oncol Hematol (2011).
4. Diaz-Laviada, I. The endocannabinoid system in prostate cancer. Nat Rev Urol 8, 553-561 (2011).
5. Scuderi, M. R. et al. The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft. Cancer Lett 310, 240-249 (2011).
6. Malfitano A. M. et al. Update on the endocannabinoid system as an anticancer target. Expert Opin Ther Targets 15, 297-308 (2011).
7. Shrivastava, A., Kuzontkoski, P. M., Groopman, J. E. & Prasad, A. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Mol Cancer Ther 10, 1161-1172 (2011).
8. Vara, D. et al. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ 18, 1099-1111 (2011).
9. Saghafi, N., Lam, D. K. & Schmidt, B. L. Cannabinoids attenuate cancer pain and proliferation in a mouse model. Neurosci Lett 488, 247-251 (2011).
10. Guindon, J. & Hohmann, A. G. The endocannabinoid system and cancer: therapeutic implication. Br J Pharmacol 163, 1447-1463 (2011).
*** The list in its entirety can be viewed via the www.cannabisscience.com website
Cannabis Science, Inc. is the front line in pharmaceutical grade medical marijuana research and development. The first formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. In time, all Americans will be able to access a safe and effective FDA approved medicine regardless of which state they live in. It is scientifically absurd to maintain that marijuana is a dangerous, addictive drug with no medical value. With no effective lethal dose, Cannabis medicines are significantly safer than aspirin, acetaminophen, and most other over the counter drugs which are responsible for the deaths of thousands of Americans each year.
(Related: Michigan Welfare Drug Testing Law Needs Medical Marihuana Exemption)
Cannabis Science, Inc. works with world authorities on phytocannabinoid science targeting critical illnesses, in addition to adhering scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. They are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
If you or someone you know is facing charges as a result of Medical Marijuana prescribed to you as a Medical Marijuana patient under the Michigan Medical Marijuana Act, contact Komorn Law and ensure your rights are protected.
Michael Komorn is recognized as a leading expert on the Michigan Medical Marihuana Act. He is the President of theMichigan Medical Marijuana Association (MMMA), a nonprofit patient advocacy group with over 26,000 members, which advocates for medical marijuana patients, and caregiver rights. Michael is also the host of Planet Green Trees Radio, a marijuana reform based show, which is broadcast every Thursday night 8-10 pm EST. Follow Komorn onTwitter.
